Organon & Co (OGN) Reports Steady Growth Amidst Market Challenges [Yahoo! Finance]
Organon & Co. (OGN)
Company Research
Source: Yahoo! Finance
Net Income : Fourth quarter net income soared to $546 million, a significant increase from $108 million in the prior year. Adjusted EBITDA : Adjusted EBITDA margin improved to 28.1% in Q4 2023 from 25.6% in Q4 2022. Biosimilars : Biosimilars revenue grew by 23% as-reported and 24% ex-FX for the full year 2023. Dividend : A quarterly dividend of $0.28 per share has been declared, payable on March 14, 2024. Guidance : Organon anticipates low-single-digit revenue growth and a stable to improving Adjusted EBITDA margin for 2024. Warning! GuruFocus has detected 4 Warning Signs with OGN. On February 15, 2024, Organon & Co ( NYSE:OGN ) released its 8-K filing , detailing its financial results for the fourth quarter and the full year ended December 31, 2023. The company, a global pharmaceutical player focused on women's health, biosimilars, and established brands, reported an 8% increase in Q4 revenue year-over-year, both as-reported and ex-FX, reaching $1,598 million. Organon
Show less
Read more
Impact Snapshot
Event Time:
OGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OGN alerts
High impacting Organon & Co. news events
Weekly update
A roundup of the hottest topics
OGN
News
- Organon & Co. (NYSE: OGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $20.00. They now have a "neutral" rating on the stock.MarketBeat
- Organon & Co. (NYSE:OGN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- What Makes Organon (OGN) a New Buy Stock [Yahoo! Finance]Yahoo! Finance
- Organon Reports Results for the First Quarter Ended March 31, 2024Business Wire
- Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store? [Yahoo! Finance]Yahoo! Finance
OGN
Earnings
- 5/2/24 - Beat
OGN
Sec Filings
- 5/3/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 4/25/24 - Form ARS
- OGN's page on the SEC website